1. Allii Macrostemonis Bulbus: A Comprehensive Review of Ethnopharmacology, Phytochemistry and Pharmacology.
- Author
-
Wu, Jianfa, Wang, Lulu, Cui, Ying, Liu, Fei, and Zhang, Jing
- Subjects
- *
BOTANICAL chemistry , *ETHNOPHARMACOLOGY , *VASCULAR endothelial cells , *CHINESE medicine , *CORONARY disease , *ANGINA pectoris , *BITTERNESS (Taste) - Abstract
The dried bulbs of Allii Macrostemonis Bulbus (AMB) are called "薤白" in China and are mainly distributed in Asia. The plant species included in the 2020 Edition of the Chinese Pharmacopoeia (ChP) are Allium macrostemon Bunge (called xiaogensuan in Chinese, A. macrostemon) and Allium chinense G. Don (called xie in Chinese, A. chinense), respectively. In the traditional Chinese medicine (TCM) theoretical system, AMB is warm in nature, acrid-bitter taste, and attributive to the heart, lung, stomach, large intestine meridian. AMB has the function of activating Yang and removing stasis, regulating Qi and eliminating stagnation. Modern pharmacological studies have shown that AMB has anti-platelet aggregation, hypolipidemic, anti-atherosclerotic, cardiomyocyte, vascular endothelial cell protection, anti-cancer, anti-bacterial, anti-asthmatic, and anti-oxidant effects. In some Asian countries, AMB is often used to treat coronary heart disease (CHD), angina pectoris (AP), asthma, and diarrhea. This review collates the botanical background, ethnopharmacology, phytochemistry, pharmacological activities, quality control, and toxicological studies of AMB, and provides an outlook on the current research deficiencies and future research priorities of AMB, intending to provide ideas for future research directions and commercial development. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF